Events

Kevin Outterson to present

There are 453K new C. difficile infections (CDI) every year and 83K recurrent infections, yet there are no licensed vaccines against this important nosocomial pathogen. The current pipeline of clinical-stage […]

Part 2: Development of antibacterial drugs targeting specific pathogens The overall goal of this series of webinars is to provide, for the non-clinical developer, an understanding of the risks of development […]

At least 2 million Americans a year contract an antibiotic-resistant infection, the Centers for Disease Control and Prevention reports. So, what can the U.S. do to safeguard public health amid […]

The AMR Challenge encourages global leaders to make formal commitments that further progress against antimicrobial resistance. Your efforts could contribute to solutions that protect humans, animals, and the environment from […]

Helping Antibacterial Development to Move Forward - New discovery platforms, novel screens and approaches are vital for the discovery of new antibacterials and for ceasing the dangerous trend of multidrug […]

The Grand Challenges Annual Meeting aims to accelerate the translation of innovation to impact to address the world’s most urgent global health and development problems. The meeting is a forum […]

Kevin Outterson to present

At the 4th Annual World Anti-Microbial Resistance Congress, over 400 stakeholders will gather in Washington D.C. to discuss critical challenges and opportunities to advance antibiotic and diagnostics development, improve antimicrobial stewardship practice and […]

The Biomedical Advanced Research and Development Authority (BARDA), a component of the U.S. Department of Health and Human Services Administration for Strategic Preparedness and Response (ASPR), invites you to participate […]